Otonomy to Participate in Two Upcoming Investor Conferences
November 16 2020 - 7:30AM
Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company
dedicated to the development of innovative therapeutics for
neurotology, today announced that management is scheduled to
participate in two upcoming virtual investor conferences.
- Evercore ISI 3rd Annual HealthCONx Conference: presentation on
December 1, 2020 at 3:05 p.m. ET / 12:05 p.m. PT. A live audio
webcast of the presentation will be available through the Events
page of the company’s website at www.otonomy.com and an archived
replay will be available shortly after the event.
- Piper Sandler 32nd Annual
Healthcare Conference: 1 on 1 investor meetings on December 2,
2020. A pre-recorded fireside chat will be accessible from November
23 to December 3, 2020 through the Events page of the company’s
website at www.otonomy.com.
About OtonomyOtonomy is a biopharmaceutical
company dedicated to the development of innovative therapeutics for
neurotology. The company pioneered the application of drug delivery
technology to the ear in order to develop products that achieve
sustained drug exposure from a single local administration. This
approach is covered by a broad patent estate and is being utilized
to develop a pipeline of products addressing important unmet
medical needs including Ménière’s disease, hearing loss, and
tinnitus. For additional information please visit
www.otonomy.com.
Contacts:
Media InquiriesSpectrum ScienceChloé-Anne RamseyVice
President404.865.3601cramsey@spectrumscience.com
Investor InquiriesWestwicke ICRRobert H. UhlManaging
Director858.356.5932robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jul 2023 to Jul 2024